- Home
- NLSP vs AIHS Comparison
NLSP vs AIHS Comparison
Compare NLSP & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- AIHS
- Stock Information
- Founded
- NLSP 2015
- AIHS 2014
- Country
- NLSP Switzerland
- AIHS China
- Employees
- NLSP N/A
- AIHS N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- AIHS Finance: Consumer Services
- Sector
- NLSP Health Care
- AIHS Finance
- Exchange
- NLSP Nasdaq
- AIHS Nasdaq
- Market Cap
- NLSP 12.4M
- AIHS 11.9M
- IPO Year
- NLSP 2021
- AIHS 2018
- Fundamental
- Price
- NLSP $2.31
- AIHS $0.32
- Analyst Decision
- NLSP
- AIHS
- Analyst Count
- NLSP 0
- AIHS 0
- Target Price
- NLSP N/A
- AIHS N/A
- AVG Volume (30 Days)
- NLSP 378.8K
- AIHS 3.1M
- Earning Date
- NLSP 07-15-2025
- AIHS 08-13-2025
- Dividend Yield
- NLSP N/A
- AIHS N/A
- EPS Growth
- NLSP N/A
- AIHS N/A
- EPS
- NLSP N/A
- AIHS N/A
- Revenue
- NLSP N/A
- AIHS $5,878,700.00
- Revenue This Year
- NLSP N/A
- AIHS N/A
- Revenue Next Year
- NLSP N/A
- AIHS N/A
- P/E Ratio
- NLSP N/A
- AIHS N/A
- Revenue Growth
- NLSP N/A
- AIHS 12.21
- 52 Week Low
- NLSP $1.30
- AIHS $0.26
- 52 Week High
- NLSP $15.59
- AIHS $1.70
- Technical
- Relative Strength Index (RSI)
- NLSP 48.87
- AIHS 33.03
- Support Level
- NLSP $2.20
- AIHS $0.27
- Resistance Level
- NLSP $3.08
- AIHS $0.33
- Average True Range (ATR)
- NLSP 0.25
- AIHS 0.03
- MACD
- NLSP -0.05
- AIHS 0.01
- Stochastic Oscillator
- NLSP 16.36
- AIHS 54.33
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About AIHS Senmiao Technology Limited
Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.